# BTT1023 in Psoriasis

> **NCT00871598** · PHASE1 · COMPLETED · sponsor: **Biotie Therapies Corp.** · enrollment: 26 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** BTT1023
- **DRUG:** Placebo
- **DRUG:** BTT1023

## Key facts

- **NCT ID:** NCT00871598
- **Lead sponsor:** Biotie Therapies Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2010-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00871598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00871598, "BTT1023 in Psoriasis". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00871598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*